AzTrials
AzTrials

Child NeglectAMIS-II-RCTNCT05128669

Child and Parent-directed Individualized Psychotherapy (CPIP)

A study testing CPIP and ECS in people with Child Neglect and Internalizing Disorder, run by University of Leipzig at 2 sites in Germany.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

With CPIP the investigators opt for a manualized modular psychotherapy designed especially to meet the needs of children with internalizing disorders that suffered or still suffer from emotional or physiological neglect. Read more about this study

Who is it for?
Ages 3 to 8 years
Conditions the study is for
Child Neglect, Internalizing Disorder
What is being tested?
CPIP and ECS
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
2 sitesGermany
Study dates
21 Jul 2020to 20 Mar 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 to 8 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Age 3 to 8
  • Sufficiently stable psychosocial situation of the child for potential participation in the study
  • Written informed consent of the patient's parents or legal guardian
  • Informed oral consent of children (from 6 years)
  • Release from professional secrecy Teacher / educator
  • Positive pre-screening for internalizing symptoms
Show all 9Show fewer
  • Confirmation that the child's psychosocial situation is sufficiently stable to participate in the study
  • physical/emotional neglect
  • DSM-5 internalizing disorder

Who cannot join

  • limited language skills of children or caregivers (caregiver: if communication severely impeded despite translators)
  • unresolved custody dispute
  • concurrent intensive psychotherapy of >3 months duration
  • participation of the child in other interventional trials
  • IQ < 70
  • autism or psychosis/schizophrenia spectrum disorder of the child

Trial locations and contacts

2 sites in 1 country.

Germany2 sites, 2 recruiting
  • University of Leipzig - Department of Child and Adolescent Psychiatry

    Leipzig, 04103

    Kai von Klitzing, Prof. Dr.

    Recruiting
  • Klinikum Rechts der Isar der Technischen Universität München- Lehrstuhl für Sozialpädiatrie

    München, 81675

    Volker Mall, Prof.Dr.

    Recruiting

Other trials in Germany

About this study

Official title: Randomized Controlled Trial of Child and Parent-directed Individualized Psychotherapy (CPIP) for Neglected Children With Internalizing Disorders

With CPIP the investigators opt for a manualized modular psychotherapy designed especially to meet the needs of children with internalizing disorders that suffered or still suffer from emotional or physiological neglect. CPIP helps the child to resolve rigid conflictual internal representations/ working models by individually focusing on caregiver-child interaction, mentalization based interventions with children and caregivers and working with the therapeutic transference relationship with the child and the caregiver. Treatment sessions will take place at CAP.

Clinical hypotheses:

Read more

The main hypothesis of the study is that for children with internalizing disorders and experience of emotional / physical neglect, CPIP \& enhanced caregiving support (intervention group) is superior in reducing internalizing symptoms compared to ECS alone (control group). Potential predictors of treatment response, as family context, gender and age, will be examined. Furthermore, the investigators will investigate possible treatment effects and mediating mechanisms, especially changes in DNA methylation profiles, HPA-dysregulation, cognitive-emotional styles, and emotional availability.

Additional elements: If the child additionally suffers from traumatic experiences of violence or sexual abuse, elements of Tf-CBT will be applied. Furthermore, elements of Interaction Guidance and ABC including video feedback will be applied in joint caregiver-child sessions. Treatment fidelity: Following the previous study, manualization, careful training and regular supervision will strive to ensure high treatment fidelity which will be systematically assessed in a random sample of two videotaped sessions per family.

Read the detailed description

Setting: Typically, 25 weekly sessions of approximately 50 minutes; in the clinician's office, family home, or child protection service office (due to the limited compliance expected from some families to attend regular therapeutic sessions). When conducting treatment sessions in the home environment, principles of established and evidence-based home visitation programs, like SafeCare or Nurse-Family Partnership Program will be applied.

Therapeutic elements: Reflective developmental guidance, modeling appropriate emotional availability, understanding of the meaning and function of the symptoms within relationships together with the caregivers, identifying and labeling feelings and actions, creation of a "neglect narrative" (parallel to a trauma narrative) and conflict interpretation together with the child.

Three treatment phases: Session 1-5: Building of a working alliance, assessment of family/individual problems and resources, focus formulation; Sessions 6-20: Therapeutic work on the focus; Session 21 to 25: Detachment of the working alliance, summarizing, concluding, fostering future development.

Therapeutic strategy: The inner conflict which is currently most pressing and actively determining the child's symptoms as well as jeopardizing mental development in the present will be identified and formulated during the first 5 sessions together with the caregivers and the child (therapeutic "focus"). The following treatment phase concentrates on the jointly identified problem/conflict that has been aggregated in the focus formulation. The setting will vary (number of parent-only, child-only, and caregiver-child sessions) as a function of whether the focus predominantly lies in the interpersonal (caregiver-child interaction) or intrapersonal realm.

Control Condition: Enhanced Caregiving Support (ECS) will serve as the control condition provided by the Allgemeine Sozialdienst (ASD - Community Social Services) of the two participating cities. According to German law (§ 27 SGB VIII), caregivers are entitled to receive caregiving support (CS; "Hilfe zur Erziehung") in cases where the child's wellbeing is jeopardized. CS generally includes supportive work across all child-relevant systems (family, neighborhood, (pre-)school, peer group etc.). Appointed social workers and educators provide parenting counseling, family support, and intensive child support according to an individualized helping plan ("Hilfeplan"). In more severe cases, children are placed in (temporary) day-care centers, children's homes, foster families etc. Within the context of the trial, the investigators will appoint an additional multi-systemic case manager to each case to enhance the quality of case coordination (enhanced CS; ECS). All children and families will receive ECS. the investigators will compare children receiving CPIP plus ECS to children receiving ECS only.

Being tested
CPIP, ECS
Keywords
emotional/physical neglect, Internalizing disorders, 3 to 8-year old children

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • CPIPProcedure or surgery

    CPIP is an innovative Child-Parent Individualized Psychotherapy, consisting of 25 sessions, designed by the PI and his clinical collaborators for children with internalizing disorders in the aftermath of childhood neglect. It is informed by Short-term Psychoanalytic Child Therapy, elements of psychoanalytic parent work, videofeedback and Child-Parent Psychotherapy (CPP) and. CPIP supports the child-caregiver relationship and helps the child to resolve rigid conflictual internal representations/working models and improve interpretative and mentalizing techniques.

  • ECSProcedure or surgery

    Enhanced Caregiving Support (ECS) will serve as the control condition provided by the Allgemeine Sozialdienst (ASD - Community Social Services) of the two participating cities. According to German law (§ 27 SGB VIII), caregivers are entitled to receive caregiving support (CS; "Hilfe zur Erziehung") in cases where the child's wellbeing is jeopardized. CS generally includes supportive work across all child-relevant systems (family, neighborhood, (pre-)school, peer group etc.). Appointed social workers and educators provide parenting counseling, family support, and intensive child support according to an individualized helping plan ("Hilfeplan"). In more severe cases, children are placed in (temporary) day-care centers, children's homes, foster families etc. Within the context of the trial, we will appoint an additional multi-systemic case manager to each case to enhance the quality of case coordination (enhanced CS; ECS). All children and families will receive ECS.

Study groups in NCT05128669
Study groupRoleWhat they receive
CPIP+ECSExperimentalCPIP is an innovative Child-Parent Individualized Psychotherapy, consisting of 25 sessions, designed by the PI and his clinical collaborators for children with internalizing disorders in the aftermath of childhood neglect. It is informed by Short-term Psychoanalytic Child Therapy (PaCT), elements of psychoanalytic parent work, videofeedback and Child-Parent Psychotherapy (CPP) and. CPIP supports the child-caregiver relationship and helps the child to resolve rigid conflictual internal representations/working models and improve interpretative and mentalizing techniques. ECS (Enhanced Caregiving Support) is described in other arm.
Receives: Procedure: CPIP; Procedure: ECS
ECS onlyActive comparatorEnhanced Caregiving Support (ECS) will serve as the control condition provided by the Allgemeine Sozialdienst (ASD - Community Social Services) of the two participating cities. According to German law (§ 27 SGB VIII), caregivers are entitled to receive caregiving support (CS; "Hilfe zur Erziehung") in cases where the child's wellbeing is jeopardized. CS generally includes supportive work across all child-relevant systems (family, neighborhood, (pre-)school, peer group etc.). Appointed social workers and educators provide parenting counseling, family support, and intensive child support according to an individualized helping plan ("Hilfeplan"). In more severe cases, children are placed in (temporary) day-care centers, children's homes, foster families etc. Within the context of the trial, we will appoint an additional multi-systemic case manager to each case to enhance the quality of case coordination (enhanced CS; ECS). All children and families will receive ECS.
Receives: Procedure: ECS

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assess superiority of CPIP in addition to Enhanced Caregiving Support (ECS) as compared to ECS alone.

    We assume superiority of CPIP \& ECS compared to ECS alone in reducing internalizing symptoms of participating children. The Child Behavior Checklist 4-18 (CBCL 4-18) - a well-established internationally used questionnaire that reliably and validly captures child internalizing symptoms. The primary efficacy endpoint (pEP) is the CBCL 4-18 internalizing symptoms score (IntS), rated by the primary caregiver at t3 (post-treatment).

    The scale ranges from 0-62 with higher scores indicating worse outcomes.

    Measured: The primary efficacy endpoint is taken 13 months after randomisation

Secondary outcomes (16)
  1. caregiver-rated internalizing symptoms for mid/long-term effects

    Caregiver-rated IntS using Child Behavior Checklist (CBCL 4-18) at t4 to assess mid/long-term effects. The scale ranges from 0-62 with higher scores indicating worse outcomes.

    Measured: 13 months after randomisation

  2. internalizing symptoms in clinical interviews

    IntS for depression and anxiety assessed using the Preschool Age Psychiatric Assessment (PAPA), administered to caregivers by trained Masters-level staff

    Measured: within 4 weeks before randomisation + 7 and 13 months after randomisation

  3. teacher-rated internalizing symptoms

    (Nursery-)teacher-rated IntS using Teacher Report Form (TRF 4-18). The scale ranges from 0-70 with higher scores indicating worse outcomes.

    Measured: within 4 weeks before randomisation + 7 and 13 months after randomisation

  4. secondary caregiver-rated internalizing symptoms

    Secondary caregiver-rated IntS using Child Behavior Checklist (CBCL 4-18). The scale ranges from 0-62 with higher scores indicating worse outcomes.

    Measured: within 4 weeks before randomisation + 7 and 13 months after randomisation

  5. child-rated internalizing symptoms

    Child self-reported internalizing symptoms using Berkeley Puppet Interview. The scale ranges from 1-182 with higher scores indicating better outcomes.

    Measured: within 4 weeks before randomisation + 7 and 13 months after randomisation

  6. Externalizing symptoms

    Externalizing symptoms (ExtS) rated by caregivers and teachers using the Child Behavior Checklist (CBCL 4-18), Teacher-report Form (TRF) and Berkeley Puppet Interview, respectively.

    The CBCL ExtS scale ranges from 0-66 with higher scores indicating worse outcomes. The TRF ExtS scale ranges from 0-68 with higher scores indicating worse outcomes.

    Measured: within 4 weeks before randomisation + 7 and 13 months after randomisation

  7. Cognitive-emotional style/mentalizing capacity

    In an exploratory fashion, the investigators will test whether the child's ability to mentalize improve after the intervention and whether improvement in this ability is a mediator of the treatment effect.

    Child's ability to mentalize assessed by the Process Scales (Hill et al., 2009) and the MacArthur Narrative Coding Manual (MNCM; Robsinson et al., 2002) using the indices for narrative coherence (range: 1-12), intentionality (range: 1-12), with higher scores indicating better outcome.

    Measured: within 4 weeks before randomisation + 7 months after randomisation

  8. Quality of the parent-child interaction (EAS)

    In an exploratory fashion, the investigators will test whether the quality of parent-child interaction improve after the intervention and whether this improvement in interaction quality is a mediator of the treatment effect.

    Quality of the parent-child interaction assessed by the Emotional Availability Scales (EAS), specifically four caregiver scales (1. sensitivity, 2. structuring, 3. nonintrusiveness, and 4. nonhostility) and two child scales (1.responsiveness to mother and 2. involvement of mother). Codes on the scales range from 1 to 7, with higher scores indicating better outcome.

    Measured: within 4 weeks before randomisation + 7 months after randomisation

  9. Cortisol secretion

    hair cortisol concentrations (HCC) in the first 3 cm scalp hair segment at posterior vertex (~cumulative secretion over last 3 months)

    Measured: within 4 weeks before randomisation + 3.5 months after randomisation + 7 and 13 months after randomisation

  10. Polygenic epigenetic risk scores

    changes in DNA methylation profiles

    Measured: within 4 weeks before randomisation + 7 months after randomisation

  11. Adherence to CPIP interventions

    number of sessions attended by primary caregiver and by child for secondary/sensitivity analyses

    Measured: 7 months after randomisation

  12. Feasibility-related endpoints - Acceptability of CPIP rated by caregivers/ parents

    Acceptability of CPIP rated by caregivers/ parents using Treatment evaluation questionnaire (Fragebogen zur Beurteilung der Behandlung - FBB)

    Measured: 7 months after randomisation

  13. Feasibility-related endpoints - Acceptability of CPIP rated by children

    Acceptability of CPIP rated by children: Items derived from the German version of Therapeutic Alliance Scales for Children (TASC)

    Measured: 7 months after randomisation

  14. Feasibility-related endpoints - Acceptability of CPIP rated by therapists

    Acceptability of CPIP rated by caregivers/ parents using Treatment evaluation questionnaire (Fragebogen zur Beurteilung der Behandlung - FBB)

    Measured: 7 months after randomisation

  15. Feasibility-related endpoints - CPIP retention rates

    Acceptability of CPIP - retention rates. We expect a high rate of retention until end of the intervention.

    Measured: 7 months after randomisation

  16. Feasibility-related endpoints - Adherence to CPIP interventions

    Adherence to CPIP interventions: coding of session videos using a Q-sort rating

    Measured: 7 months after randomisation

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted22 Nov 2021
  2. Study start21 Jul 2020
  3. Primary completion20 Dec 2024 (estimated)
  4. Study completion20 Mar 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
2 arms, randomized assignment to intervention group (CPIP + ECS) or control group (ECS only), single masked (outcomes assessor), multi-centre trial
Masking
None (open label)
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05128669
Sponsor's protocol ID
AMIS-II-RCT
Other IDs
01KR1802A
Acronym
AMIS-II-RCT
Status last verified
Jun 2023
First submitted
11 Jan 2021
Last updated
15 Jun 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: After publication of the primary objective, published data might be provided to interested scientists on request (e.g. for meta-analyses, health related registers or other scientific questions) in an anonymized way within 5 years, if the members of the AMIS-II-trial group agree.

Questions about this trial

What is this clinical trial studying?

A study testing CPIP and ECS in people with Child Neglect and Internalizing Disorder, run by University of Leipzig at 2 sites in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 15 Jun 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Lars Otto White, Dr. phil (+49 (0) 341 - 9724018, LarsOtto.White@medizin.uni-leipzig.de), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assess superiority of CPIP in addition to Enhanced Caregiving Support (ECS) as compared to ECS alone. (time frame: The primary efficacy endpoint is taken 13 months after randomisation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jun 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in